Skip to content
10-K

Annual Report

AEOLUS PHARMACEUTICALS, INC.

0001102624-15-001827

← back to feed
Filed
Dec 18, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Dec 18, 2015 151.56M sh
Shares Diluted FY 2015 · Sep 30, 2014 134.67K sh
Operating Cash Flow FY 2015 · Sep 30, 2014 $323K
Current Liabilities FY 2015 · Sep 30, 2014 $2M
Total Liabilities FY 2015 · Sep 30, 2014 $2M
Current Assets FY 2015 · Sep 30, 2014 $3.55M
Total Assets FY 2015 · Sep 30, 2014 $3.58M
Eps Diluted FY 2015 · Sep 30, 2014 $0.00
Eps Basic FY 2015 · Sep 30, 2014 $0.00
Sga Expense FY 2015 · Sep 30, 2014 $2.75M
Rd Expense FY 2015 · Sep 30, 2014 $6.97M
Net Income FY 2015 · Sep 30, 2014 −$80K
Operating Income FY 2015 · Sep 30, 2014 −$80K
Cash And Equivalents FY 2015 · Sep 30, 2013 $869K
Stockholders Equity FY 2015 · Sep 30, 2013 $705K